Unique ID issued by UMIN | UMIN000042698 |
---|---|
Receipt number | R000048729 |
Scientific Title | An ancillary study of (a randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer)-exploratory study of cost-effectiveness |
Date of disclosure of the study information | 2020/12/09 |
Last modified on | 2023/06/12 09:02:23 |
An ancillary study of (a randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer)-exploratory study of cost-effectiveness
LOGIK1702-B
An ancillary study of (a randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer)-exploratory study of cost-effectiveness
LOGIK1702-B
Japan |
Non-small-cell lung cancer
Pneumology | Chest surgery |
Malignancy
NO
We investigate the cost-effectiveness of each adjuvant chemotherapy in patients who enrolled in LOGIK1702 study (UMIN000027435)entitled (a randomized phase 2 study of TS-1 versus CDDP+VNR for adjuvant therapy in patients with non-small cell lung cancer)
Others
Cost minimization analysis, cost effectiveness ratio (CER), incremental cost effectiveness ratio (ICER), cost utility ratio, Incremental cost-utility ratio
Exploratory
Not applicable
Cost-minimization analysis, cost- effectiveness ratio (CER), incremental cost-effectiveness ratio (ICER), cost-utility ratio, incremental cost-utility ratio
Others,meta-analysis etc
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1) Patients enrolled in LOGIK1702
2) Patients providing the written informed consent.
Nothing particular
110
1st name | Takeshi |
Middle name | |
Last name | Nagayasu |
Nagasaki University Graduate School of Biomedical Sciences
Department of Surgical Oncology
852-8501
1-7-1 Sakamoto, Nagasaki, Nagasaki 852-8501, Japan
095-819-7304
nagayasu@nagasaki-u.ac.jp
1st name | Tomoshi |
Middle name | |
Last name | Tsuchiya |
Toyama University Hospital
Respiratory surgery
930-0194
2630 Sugitani,Toyama, Toyama
076-434-7371
tomoshi@nagasaki-u.ac.jp
Clinical Research Support Center Kyushu
none
Self funding
Lung Oncology Group in Kyushu (LOGIK)
Nagasaki University Hospital Clinical Research Ethic Committee
1-7-1 Sakamoto, Nagasaki, Nagasaki 852-8501, Japan
095-819-7905
gaibushikin@ml.nagasaki-u.ac.jp
NO
長崎大学病院(長崎県)
2020 | Year | 12 | Month | 09 | Day |
Unpublished
No longer recruiting
2020 | Year | 09 | Month | 28 | Day |
2020 | Year | 11 | Month | 04 | Day |
2021 | Year | 01 | Month | 04 | Day |
2027 | Year | 05 | Month | 31 | Day |
1)Expense data collected
All direct medical expenses (insurance points) in conjunction with adjuvant chemotherapy that cost during one and half years after adjuvant chemotherapy.
The following expenses are also included.
・Medical expenses cost for a recurrence and an adverse event
・Medical expenses cost for a postoperative complication
・Medical expenses cost for the underlying disease that patients originally have
2) Analysis method
According to National Institute for Health and Clinical Excellence (NICE) guideline and analysis guideline of cost-effectiveness estimation in Japanese Central Social Insurance Conference (Jan. 2016), the following three analyses are considered.
1) Cost-minimization analysis
The analysis is carried out only if the effectiveness is judged to be similar by the investigator.
2) Cost-effectiveness analysis
Cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER)
3) Cost-utility analysis
2020 | Year | 12 | Month | 09 | Day |
2023 | Year | 06 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048729
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |